Form 4 holding
CEO, Director
Aridis Pharmaceuticals, Inc.
- Security class
- Common stock purchase
- Shares / value
- 1,378,639
- Estimated value
- $96,505
- Report date
- 24 Jun 2024
- Price
- $0.0700
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|